← Browse by Condition
Medical Condition
hemophilia b
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 3, Phase 1
NCT05145127 Phase 3
Recruiting
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Enrollment
245 pts
Location
United States, Austr...
Sponsor
Pfizer
NCT05709288 Phase 1
Recruiting
Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old
Enrollment
9 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
NCT06147414
Recruiting
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Enrollment
550 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT05630651
Recruiting
The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.
Enrollment
6 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
NCT06003387 Phase 3
Recruiting
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
Enrollment
35 pts
Location
United States, Austr...
Sponsor
CSL Behring